The underlying mechanism was partially associated with increased BDNF expression, the inhibition of Aβ and tau expression, and reduced AChE activity while subsequently attenuating neuronal damage from oxidative stress in the hippocampal CA1 and CA3 regions of ICR mice with scopolamine-induced AD [114]. This evidence concerns the gene MAPT and Alzheimer disease.